The Algerian Ministry of Health has entered into a formal cooperation agreement with the German pharmaceutical company Boehringer Ingelheim to bolster the management of stroke cases and rare diseases. Overseen by the Minister of Health, the signing ceremony highlighted a commitment to enhancing the capabilities of medical professionals and accelerating the digitalization of stroke care pathways. The agreement focuses on improving coordination among health stakeholders and utilizing evidence-based scientific data to better assess medical needs. Ultimately, this partnership seeks to improve the quality of patient care, prioritize early diagnosis, and strengthen the overall performance of the national health system.